CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...
Boeing's Record Disappointment
The Boeing Company faces short-term struggles with negative operating cash flow, but it has a strong cash position and ...
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update
Reported a robust objective response rate of 75.5% from the Phase 1 study of NX-5948 in patients with relapsed/refractory CLL/SLL at the 66th ...
Investopedia3d
How To Buy Treasury Securities
David Gonzalez, CMT, has 24+ years of experience working in several areas of the financial industry, currently as an independent FX trader. Charlene Rhinehart is a CPA , CFE, chair of an Illinois ...
Lynnwood Times4d
Boeing Reports Preliminary Fourth Quarter Results
The Boeing Company announced on Thursday, January 23, it will recognize impacts to its financial results related to the IAM ...
Where to Stash Your Cash: Today's Top Rates on Savings Accounts, CDs, Treasuries, and Brokerage Accounts
If you have idle funds you want to keep accessible, you can still put the money to work earning a great return. We lay out ...